Blog

A narrated timeline of Midven and the region’s history over the last quarter century Since 1993, Midven has seen and been a part of a lot of exciting changes in the Midlands. Our region has grown from strength to strength, and Midven is proud to be a part of its fabric. Over the past 25 […]

read more

On 10 August 2018, Japanese Astellas Pharma bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorders. Midven’s UK Innovation & Science Seed Fund (UKI2S) was the founding investor with follow-on, co-investment from Cambridge Enterprise. Kenji Yasukawa, Ph.D., President and CEO of […]

read more

Midven hosts series of regional investment readiness workshops in 2018 for Midlands entrepreneurs We are excited to build upon our 25-year history investing in early-stage businesses with the management of the new £35m West Midlands equity fund, part of the Midlands Engine Investment Fund (MEIF). As we expand our venture work to invest this £35m […]

read more

1 2 3 5
Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now

×